Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 6577

1.

Influenza vaccination in HIV-infected individuals: Systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety.

Remschmidt C, Wichmann O, Harder T.

Vaccine. 2014 Aug 12. pii: S0264-410X(14)01083-4. doi: 10.1016/j.vaccine.2014.07.101. [Epub ahead of print]

PMID:
25131742
[PubMed - as supplied by publisher]
2.

Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: A comparative effectiveness study using the Valencia health care information system.

Puig-Barberà J, Natividad-Sancho A, Calabuig-Pérez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martínez-Úbeda S, Díez-Domingo J.

Vaccine. 2014 Aug 12. pii: S0264-410X(14)01077-9. doi: 10.1016/j.vaccine.2014.07.095. [Epub ahead of print]

PMID:
25131737
[PubMed - as supplied by publisher]
3.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2014-15 Influenza Season.

Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.

MMWR Morb Mortal Wkly Rep. 2014 Aug 15;63(32):691-7.

PMID:
25121712
[PubMed - in process]
Free Article
4.

Influenza Vaccination and Associated Factors among Korean Cancer Survivors : A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys.

Choi KH, Park SM, Lee K, Lee JH, Park JS.

J Korean Med Sci. 2014 Aug;29(8):1061-8. doi: 10.3346/jkms.2014.29.8.1061. Epub 2014 Jul 30.

PMID:
25120314
[PubMed - in process]
Free PMC Article
5.

Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, Martin E, Gurunathan S, Nathan R, Greenberg DP, Tornieporth NG, Decker MD, Talbot HK.

N Engl J Med. 2014 Aug 14;371(7):635-45. doi: 10.1056/NEJMoa1315727.

PMID:
25119609
[PubMed - indexed for MEDLINE]
6.

Epidemiology of Viral-Associated Acute Lower Respiratory Tract Infection among Children <5 Years of Age in a High HIV Prevalence Setting, South Africa, 2009-2012.

Cohen C, Walaza S, Moyes J, Groome M, Tempia S, Pretorius M, Hellferscee O, Dawood H, Chhagan M, Naby F, Haffejee S, Variava E, Kahn K, Nzenze S, Tshangela A, von Gottberg A, Wolter N, Cohen AL, Kgokong B, Venter M, Madhi SA.

Pediatr Infect Dis J. 2014 Aug 4. [Epub ahead of print]

PMID:
25093972
[PubMed - as supplied by publisher]
7.

Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.

Yang P, Thompson MG, Ma C, Shi W, Wu S, Zhang D, Wang Q.

Vaccine. 2014 Aug 1. pii: S0264-410X(14)01050-0. doi: 10.1016/j.vaccine.2014.07.083. [Epub ahead of print]

PMID:
25092635
[PubMed - as supplied by publisher]
8.

Immunogenicity and safety of AS03<sub>A</sub>-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years.

Godeaux O, Izurieta P, Madariaga M, Dramé M, Li P, Vaughn DW.

Vaccine. 2014 Jul 30. pii: S0264-410X(14)01014-7. doi: 10.1016/j.vaccine.2014.07.062. [Epub ahead of print]

PMID:
25090645
[PubMed - as supplied by publisher]
9.

Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study.

Spadea A, Unim B, Colamesta V, Meneghini A, D'Amici AM, Giudiceandrea B, La Torre G.

Vaccine. 2014 Aug 1. pii: S0264-410X(14)01044-5. doi: 10.1016/j.vaccine.2014.07.077. [Epub ahead of print]

PMID:
25087677
[PubMed - as supplied by publisher]
10.

Impaired heterologous immunity in aged ferrets during sequential influenza A H1N1 infection.

Paquette SG, Huang SS, Banner D, Xu L, Leόn A, Kelvin AA, Kelvin DJ.

Virology. 2014 Jul 30;464-465C:177-183. doi: 10.1016/j.virol.2014.07.013. [Epub ahead of print]

PMID:
25086242
[PubMed - as supplied by publisher]
11.

Assessing the Ability of an Immunization Information System to Prevent Overimmunization of Pediatric Influenza Vaccines.

Carlton CA, Potter RC, Vranesich PA, Swanson RG.

J Public Health Manag Pract. 2014 Jul 31. [Epub ahead of print]

PMID:
25084536
[PubMed - as supplied by publisher]
12.

Innate Immune Sensing and Response to Influenza.

Pulendran B, Maddur MS.

Curr Top Microbiol Immunol. 2014 Jul 31. [Epub ahead of print]

PMID:
25078919
[PubMed - as supplied by publisher]
13.

Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.

Couch RB, Bayas JM, Caso C, Mbawuike IN, López CN, Claeys C, El Idrissi M, Hervé C, Laupèze B, Oostvogels L, Moris P.

BMC Infect Dis. 2014 Jul 30;14:425. doi: 10.1186/1471-2334-14-425.

PMID:
25078387
[PubMed - in process]
Free Article
14.

Immunization Safety Review: Influenza Vaccines and Neurological Complications.

Institute of Medicine (US) Immunization Safety Review Committee; Stratton K, Alamario DA, Wizemann T, McCormick MC, editors.

Washington (DC): National Academies Press (US); 2004.

PMID:
25057683
[PubMed]
Books & Documents
15.

National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2013.

Elam-Evans LD, Yankey D, Jeyarajah J, Singleton JA, Curtis RC, MacNeil J, Hariri S; Immunization Services Division, National Center for Immunization and Respiratory Diseases.

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):625-33.

PMID:
25055186
[PubMed - in process]
Free Article
16.

Comparison of the safety and immunogenicity of an MF59(®)-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.

Frey SE, Reyes MR, Reynales H, Bermal NN, Nicolay U, Narasimhan V, Forleo-Neto E, Arora AK.

Vaccine. 2014 Sep 3;32(39):5027-34. doi: 10.1016/j.vaccine.2014.07.013. Epub 2014 Jul 18.

PMID:
25045825
[PubMed - in process]
17.

Seasonal influenza vaccination trends from 2007-2011 in privately insured children and adults in the United States.

Antonova E, Ambrose CS, Kern D, Block SL, Caspard H, Tunceli O.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00935-9. doi: 10.1016/j.vaccine.2014.07.009. [Epub ahead of print]

PMID:
25045823
[PubMed - as supplied by publisher]
18.

Skin Immunization with Influenza Vaccines.

Skountzou I, Compans RW.

Curr Top Microbiol Immunol. 2014 Jul 20. [Epub ahead of print]

PMID:
25038939
[PubMed - as supplied by publisher]
19.

Inactivated and Adjuvanted Influenza Vaccines.

Del Giudice G, Rappuoli R.

Curr Top Microbiol Immunol. 2014 Jul 20. [Epub ahead of print]

PMID:
25038938
[PubMed - as supplied by publisher]
20.

Dissecting the Immune-Response to MF59®-Adjuvanted and Non-Adjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age.

Zedda L, Forleo-Neto E, Vertruyen A, Raes M, Marchant A, Jansen W, Clouting H, Arora A, Beatty ME, Galli G, Del Giudice G, Castellino F.

Pediatr Infect Dis J. 2014 Jul 16. [Epub ahead of print]

PMID:
25037034
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk